Corix Bioscience, Inc.
CXBS
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | |||
|---|---|---|---|---|---|
| Net Income | -102.84% | 13.84% | 13.84% | ||
| Total Depreciation and Amortization | 850.00% | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 191.22% | -69.79% | -69.79% | ||
| Change in Net Operating Assets | -26,977.78% | 747.23% | 747.23% | ||
| Cash from Operations | -206.37% | -13.17% | -13.17% | ||
| Capital Expenditure | -1,500.00% | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 36,980.85% | 385.73% | 385.73% | ||
| Cash from Investing | 23,446.21% | 446.66% | 446.66% | ||
| Total Debt Issued | -1.49% | 11.46% | 11.46% | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -99.92% | -- | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -6,964.48% | -111.47% | -111.47% | ||
| Cash from Financing | -319.75% | -55.51% | -55.51% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 163.26% | 237.45% | 237.45% | ||